What distinguishes a Bovine Ultralong CDR3 Antibody from a Camelid VHH?

Both are excellent for binding hidden epitopes. However, VHHs are single-domain fragments (~15kDa). Bovine Ultralong antibodies are full-sized IgGs (~150kDa) where the binding specificity is driven almost entirely by the ultralong CDR3 heavy chain. The Bovine CDR3 "knob" is structurally distinct and offers a unique cysteine-rich chemical space different from VHHs.

Is the Bovine Ultralong CDR3 Antibody Generation service suitable for therapeutic development?

Yes, but humanization is typically required. The "knob" domain is the critical binding unit. We offer services to graft this knob onto human antibody scaffolds or use it as a standalone fusion protein, minimizing the risk of anti-drug antibodies (ADA) in clinical settings.

Why do you use Phage Display instead of Hybridoma for this service?

Hybridoma technology can be inefficient for recovering ultralong CDR3 clones due to fusion inefficiencies and potential instability of specific B-cell clones. Phage display allows us to screen millions of clones simultaneously and physically links the genotype (sequence) to the phenotype (binding), making it the superior choice for isolating these rare and complex antibody architectures.

Can you generate antibodies against non-protein antigens?

While proteins are the primary target, the immune antibody library approach can be adapted for haptens or complex carbohydrates, provided they are conjugated to a strong carrier protein to elicit a T-cell dependent immune response in the bovine host.

Advanced Bovine Ultralong CDR3 Antibody Generation Service

Background Platform Application Advantage Related Services FAQ Online Inquiry

At Creative Biolabs, we understand that the most promising therapeutic targets are often the most difficult to access. Conventional antibody formats frequently fail to bind to recessed epitopes found in G-protein-coupled receptors (GPCRs), ion channels, and viral envelope glycoproteins. To overcome these barriers, we proffer our premier Bovine Ultralong CDR3 Antibody Generation service. Leveraging over 20 years of expertise in antibody discovery, we utilize advanced phage display technology to construct and screen immune antibody libraries derived from immunized cattle, delivering high-affinity antibodies with unique structural capabilities.

Discuss Your Project Today

Structural Biology of Bovine Ultralong CDR3s

Bovine antibodies are an anomaly in nature—in the best possible way. Approximately 10% of the bovine antibody repertoire consists of antibodies with an exceptionally long Complementarity Determining Region 3 (CDR3) in the heavy chain. While human CDR3s typically average 12-16 amino acids, Bovine Ultralong CDR3 Antibodies can possess CDR3s ranging from 50 to over 60 amino acids.

This unique structure forms a "stalk" and a tightly folded "knob" domain, stabilized by diverse disulfide bonds. This architecture allows these antibodies to penetrate deep immune-silent clefts and canyons on antigen surfaces that are sterically inaccessible to standard, flat-interface human or murine IgGs.

Fig. 1 Bovine Fv crystal structures and sequence alignment of the CDRH3 regions.¹

The "Knob-on-Stalk" Micro-Antibody

The architecture mimics a "micro-antibody" sitting atop a standard antibody base.

The Stalk: Composed of ascending and descending strands from the antibody $\beta$-sheet, rich in Glycine, providing flexibility and extension.
The Knob: A cysteine-rich domain where the actual antigen-binding occurs. The diversity of disulfide patterns in the knob creates a vast combinatorial library of shapes.

Table 1. Comparison of Antibody Architectures

Feature	Human IgG	Standard Bovine IgG	Bovine Ultralong CDR3 IgG
CDR3H Length	10-20 AA	20-30 AA	50-70 AA
Structure	Loop	Extended Loop	Knob and Stalk
Binding Interface	Flat / Planar	Slightly Undulating	Protruding / Penetrating
Target Accessibility	Surface Epitopes	Surface Epitopes	Recessed/Cryptic Epitopes
Disulfide Bonds	Conserved	Standard	High Diversity (Odd Cysteines)

Technology Platform: Phage Display-Based Generation

At Creative Biolabs, we do not rely on naive libraries for this complex format. We employ a robust construction and screening of immune antibody library strategy. This ensures that the antibodies we harvest have already undergone somatic hypermutation in vivo within the bovine host, guaranteeing higher affinity and stability.

Workflow: From Immunization to Validated Lead

Our Bovine Ultralong CDR3 Antibody Generation by phage display immune antibody library workflow is a comprehensive, multi-step process designed to maximize diversity and recovery of high-value clones.

Phase 1: Bovine Immunization and Immune Response

We begin by immunizing cattle with your specific antigen. Bovine immune systems are robust; however, eliciting the ultralong CDR3 lineage requires specific adjuvant strategies and scheduling.

Host: Healthy or special bovine strains.
Antigen Formats: Recombinant proteins, DNA immunization, or cell-based immunization (for GPCRs).
Monitoring: Serum titer analysis via ELISA to ensure a strong specific IgG response.

Phase 2: Immune Antibody Library Construction

This is the critical technical differentiator. Standard PCR methods often fail to amplify ultralong CDR3s due to their length and repetitive sequences.

PBMC Isolation: Harvesting B-cells from the immunized animal.
RNA Extraction & cDNA Synthesis: High-fidelity reverse transcription.
Specialized PCR Amplification: We use proprietary primer sets designed to amplify the ultralong VDJ rearrangements without bias/truncation.
Vector Ligation: Cloning into our optimized phage display vectors (M13 system).
Quality Control: We verify the immune antibody library for Bovine Ultralong CDR3 Antibody Generation size (typically >10⁹ CFU) and insert diversity.

Phase 3: Phage Display Screening (Bio-panning)

We utilize the immune antibody library to perform multiple rounds of bio-panning.

Selection: Panning against the target antigen (solid phase or solution phase).
Stringency Control: We increase washing stringency in successive rounds to select for the highest affinity binders (off-rate screening).
Deep Sequencing: Analysis of the CDR3 pools to identify enriched "knob" motifs.

Phase 4: Expression and Validation

Soluble Expression: Production of identifying ScFv or Fab fragments in E. coli or mammalian cells.
Binding Characterization: SPR (Biacore) or BLI (Octet) kinetics measurement.
Epitope Mapping: Verifying the antibody binds the intended recessed epitope.

Key Applications of Bovine Ultralong CDR3 Antibodies

The Bovine Ultralong CDR3 Antibody is a problem-solver for the biopharmaceutical industry's most challenging targets.

GPCRs and Ion Channels

These multi-pass membrane proteins often have their functional sites buried within the transmembrane bundles. The "stalk" of the bovine antibody acts as a probe, extending the "knob" into these crevices to modulate function (agonist/antagonist activity).

Broadly Neutralizing Antivirals

Viral envelope proteins (like HIV gp120 or Influenza Hemagglutinin) are heavily glycosylated (covered in sugars) to shield themselves from the immune system. However, these "glycan shields" often have small holes leading to conserved binding sites. Bovine Ultralong CDR3 Antibodies can pierce this glycan shield to neutralize the virus.

Enzyme Inhibition

By reaching into the active site (catalytic cleft) of an enzyme, these antibodies can act as potent competitive inhibitors, a feat difficult for flat human IgGs.

Why Creative Biolabs?

20+ Years of Experience: We have been at the forefront of antibody engineering since the early days of phage display.
High Success Rate: Our optimized immune antibody library for Bovine Ultralong CDR3 Antibody Generation protocols significantly increase the likelihood of retrieving stable, high-affinity binders.
Deep Sequencing Analysis: We don't just pick colonies; we analyze the repertoire landscape to ensure we capture the full diversity of the immune response.
Customizable Solutions: From antigen preparation to final validation, every step is tailored to your specific project needs.

Explore Our Comprehensive Services

While our phage display immune antibody library platform is a powerful engine, we offer a comprehensive suite of discovery technologies to ensure we always use the right tool for the job. Our Monoclonal Antibody Generation from Various Immunized Antibody Libraries Services:

Trust Creative Biolabs and our proven Bovine Ultralong CDR3 Antibody Generation by phage display immune antibody library platform to deliver the high-quality reagents you need.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQs)

Q: What distinguishes a Bovine Ultralong CDR3 Antibody from a Camelid V_HH?
A: Both are excellent for binding hidden epitopes. However, V_HHs are single-domain fragments (~15kDa). Bovine Ultralong antibodies are full-sized IgGs (~150kDa) where the binding specificity is driven almost entirely by the ultralong CDR3 heavy chain. The Bovine CDR3 "knob" is structurally distinct and offers a unique cysteine-rich chemical space different from V_HHs.
Q: Is the Bovine Ultralong CDR3 Antibody Generation service suitable for therapeutic development?
A: Yes, but humanization is typically required. The "knob" domain is the critical binding unit. We offer services to graft this knob onto human antibody scaffolds or use it as a standalone fusion protein, minimizing the risk of anti-drug antibodies (ADA) in clinical settings.
Q: Why do you use Phage Display instead of Hybridoma for this service?
A: Hybridoma technology can be inefficient for recovering ultralong CDR3 clones due to fusion inefficiencies and potential instability of specific B-cell clones. Phage display allows us to screen millions of clones simultaneously and physically links the genotype (sequence) to the phenotype (binding), making it the superior choice for isolating these rare and complex antibody architectures.
Q: Can you generate antibodies against non-protein antigens?
A: While proteins are the primary target, the immune antibody library approach can be adapted for haptens or complex carbohydrates, provided they are conjugated to a strong carrier protein to elicit a T-cell dependent immune response in the bovine host.

Reference

Dong, Jinhui, et al. "Structural diversity of ultralong CDRH3s in seven bovine antibody heavy chains." Frontiers in immunology 10 (2019): 558. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fimmu.2019.00558

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.